✦ LIBER ✦

Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case–control diffusion imaging study

✍ Scribed by R. Zivadinov; Sara Hussein; Milena Stosic; Jacqueline Durfee; Jennifer L. Cox; Diane L. Cookfair; Komal Hashmi; Nadir Abdelrahman; Neeta Garg; Michael G. Dwyer; B. Weinstock-Guttman

Book ID: 119343503
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 147 KB
Volume: 18
Category: Article
ISSN: 0928-4680
DOI: 10.1016/j.pathophys.2010.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Glatiramer acetate recov

Corrigendum to “Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis: A case–control diffusion imaging study” [Pathophysiology 18 (2011) 61–68]

✍ R. Zivadinov; Sara Hussein; Milena Stosic; Jacqueline Durfee; Jennifer L. Cox; K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effects of oral glatiramer acetate on cl

Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study

✍ Massimo Filippi; Jerry S Wolinsky; Giancarlo Comi 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 185 KB

Effect of glatiramer acetate on conversi

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

✍ G Comi; V Martinelli; M Rodegher; L Moiola; O Bajenaru; A Carra; I Elovaara; F F 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 180 KB

Abnormal subcortical deep-gray matter su

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study

✍ Robert Zivadinov; Mari Heininen- Brown; Claudiu V. Schirda; Guy U. Poloni; Niels 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 547 KB

European/Canadian multicenter, double-bl

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

✍ Giancarlo Comi; Massimo Filippi; Jerry S. Wolinsky 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

## Abstract Two prior double‐blind, placebo‐controlled, randomized trials demonstrated that glatiramer acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis (RRMS). This study was designed to determine the effect, onset, and durability of any effect of GA on dis